Study to Evaluate the Effects of the Cooling Bolero in Women With Common Menopause Symptoms
|ClinicalTrials.gov Identifier: NCT02795741|
Recruitment Status : Completed
First Posted : June 10, 2016
Last Update Posted : June 14, 2018
The Cooling Bolero is a a vest filled with a new material (not ice or a gel) that provides controlled cooling by absorbing heat. The vest is manufactured by Nanohealth. It intended to provide moderate cooling (~15C/59F) through indirect contact with the skin. The material in the device is safe, non-toxic, and eco-friendly.
Recent anecdotal studies of women with common peri-menopausal and menopausal symptoms (hot flashes, night sweats, flushing/sweating of face and neck, and intermittent sleep disturbances) have shown a reduction in both the frequency and intensity of those symptoms after using the Cooling Bolero. Specific (moderate) temperature cooling of the neck and upper torso appears to target and mitigate these common menopausal symptoms. This pilot study attempts to collect additional data on the effects of the Cooling Bolero.
|Condition or disease||Intervention/treatment||Phase|
|Menopause Symptoms||Device: Cooling Bolero||Not Applicable|
Participants who have consented for this study will first be asked to complete a Baseline Assessment of their menopausal symptoms, including documentation of their baseline weight. If the assessment indicates that the participant has at least 'moderate' menopausal symptoms, then she will then enter the Run-In Period.
During the two-week Run-In Period, participants will use a Symptom Diary for to document the frequency and severity of their menopausal symptoms. At the start of Week 3, participants will return their completed Run-In Period Symptom Diary and receive their Cooling Bolero with instructions on how to use the product during the Treatment Period.
During the Treatment Period, participants should use the Cooling Bolero at least two times per day (morning and evening) for one hour. As feasible, the participant should start to wear the product 30 minutes prior to meal time for these two applications. The participant may also wear the product at additional times, as desired. All applications of the Cooling Bolero during the four-week Treatment Period are to be documented in the Product/Symptom Diary. During the Treatment Period, the participant will also continue to document the frequency and severity of their menopausal symptoms in the Product/Symptom Diary.
At the end of Week 6, the participant will stop using the Cooling Bolero. She will be asked to complete a Product Assessment and have her weight documented.
Participants will be contacted at Week 10 to ask about the status of menopausal symptoms after four weeks of not using the Cooling Bolero.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||15 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Pilot Study to Evaluate the Effects of the Nanohealth, Inc. Cooling Bolero in Women With Common Menopause Symptoms|
|Study Start Date :||July 2016|
|Actual Primary Completion Date :||March 2018|
|Actual Study Completion Date :||May 2018|
Experimental: Cooling Bolero
All participants will use the Cooling Bolero for one month
Device: Cooling Bolero
a vest filled with a new material (not ice or a gel) that provides controlled cooling by absorbing heat
- Number of participants with a reduction in the frequency and/or intensity of menopause symptoms [ Time Frame: one month ]Diaries will be used to capture data pre-intervention, during the intervention, and post-intervention
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02795741
|United States, New Jersey|
|Englewood Hospital and Medical Center|
|Englewood, New Jersey, United States, 07631|
|Principal Investigator:||David Abramson, MD||Englewood Hospital and Medical Center|